Aspira Women's Health Faces Delisting Concerns
Ticker: AWHL · Form: 8-K · Filed: Apr 16, 2025 · CIK: 926617
Sentiment: bearish
Topics: delisting, listing-standards, 8-k
TL;DR
Aspira Women's Health might get delisted, filing an 8-K about listing rule issues.
AI Summary
Aspira Women's Health Inc. filed an 8-K on April 16, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing also includes financial statements and exhibits. The company's principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Why It Matters
This filing indicates potential issues with Aspira Women's Health Inc.'s compliance with stock exchange listing requirements, which could lead to the delisting of its shares.
Risk Assessment
Risk Level: high — A notice of delisting or failure to meet listing standards is a significant negative event that can severely impact a company's stock.
Key Players & Entities
- Aspira Women's Health Inc. (company) — Registrant
- April 15, 2025 (date) — Earliest event reported
- April 16, 2025 (date) — Date of report
- 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738 (address) — Principal executive offices
- VERMILLION, INC. (company) — Former company name
- CIPHERGEN BIOSYSTEMS INC (company) — Former company name
- ABIOTIC SYSTEMS (company) — Former company name
FAQ
What specific listing rule or standard has Aspira Women's Health Inc. failed to satisfy?
The filing does not specify the exact listing rule or standard that Aspira Women's Health Inc. has failed to satisfy, only that a notice has been issued.
What is the date of the earliest event reported in this 8-K filing?
The earliest event reported is dated April 15, 2025.
What is the primary purpose of this 8-K filing?
The primary purpose is to report a notice of delisting or failure to satisfy a continued listing rule or standard, and to include financial statements and exhibits.
Where are Aspira Women's Health Inc.'s principal executive offices located?
The principal executive offices are located at 12117 Bee Caves Road, Building Three, Suite 100, Austin, TX 78738.
Has Aspira Women's Health Inc. had previous name changes?
Yes, the company was formerly known as VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC, and ABIOTIC SYSTEMS.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Aspira Women's Health Inc. (AWHL).